Cancerbackup: Hormone therapy

Skip the page content navigation if you do not require links to content sections within this page.

Page Content Navigation

Skip the main banner if you do not want to read it as the next section.


Page Banner

Want to speak to a specialist cancer nurse? Call free on 0808 800 1234



Skip the main content if you do not want to read it as the next section.


Hormone therapy for locally advanced prostate cancer

For most men with locally advanced prostate cancer, hormone therapy started immediately after diagnosis significantly reduces tumour progression and delays metastases. But the degree of benefit in different patients is still to be defined.(2),(3)

For many men with locally advanced disease, hormone therapy alone is enough to control the disease for many years. It may be the treatment of choice for many elderly men.

Studies have shown little difference in efficacy between surgical castration and LHRH analogues and between LHRH analogues and the anti-androgen drug bicalutamide (Casodex).

The advantage of bilateral orchidectomy is that it is a one-off treatment while the disadvantage is that it is irreversible. Many men find it unacceptable as it has negative psychological effects.

LHRH analogues are often the chosen form of hormonal therapy. Their side effects include lethargy, hot flushes, weight gain and loss of sexual function. Long term use affects bone density and is linked with an increased risk of fracture.

Some men may choose anti-androgens (bicalutamide) instead of an LHRH analogue because it offers them the possibility of remaining sexually active. The main side effects of bicalutamide are breast enlargement (gynaecomastia) and breast pain. 


Content last reviewed: 01 February 2008
Page last modified: 06 March 2008

Get support

Look for other people in the same situation on our What Now? community - read their blogs or talk to them in our chat rooms.

Find out about other ways to get support on the main Macmillan website.

Patient information